Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402CAIRNCROSS, Gregory; MEIHUA WANG; MEHTA, Minesh et al.Journal of clinical oncology. 2013, Vol 31, Num 3, pp 337-343, issn 0732-183X, 7 p.Article

The treatment of anaplastic oligodendrogliomas and mixed gliomas. CommentsKYRITSIS, A. P; YUNG, W. K. A; BRUNER, J et al.Neurosurgery. 1993, Vol 32, Num 3, pp 365-371, issn 0148-396XArticle

Bevacizumab for Recurrent Alkylator-Refractory Anaplastic OligodendrogliomaCHAMBERLAIN, Marc C; JOHNSTON, Sandra.Cancer. 2009, Vol 115, Num 8, pp 1734-1743, issn 0008-543X, 10 p.Article

Role of intraoperative smear cytology in the diagnosis of anaplastic oligodendroglioma: A case reportGOH, Seng Geok; KHOON LEONG CHUAH.Acta cytologica. 2003, Vol 47, Num 2, pp 293-298, issn 0001-5547, 6 p.Article

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapyCHINOT, Oliver-Louis; HONORE, Stephane; DUFOUR, Henry et al.Journal of clinical oncology. 2001, Vol 19, Num 9, pp 2449-2455, issn 0732-183XArticle

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasCAIRNCROSS, J. G; UEKI, K; RAMSAY, D. A et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 19, pp 1473-1479, issn 0027-8874Article

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951GORLIA, Thierry; DELATTRE, Jean-Yves; VAN DEN BENT, Martin J et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3477-3485, issn 0959-8049, 9 p.Article